Jana Schembera is a pharmacist by training and a PhD student in the group of Prof. Regina Scherließ at Kiel University. The aim of her doctoral thesis is the development of an inhalable dry powder platform for mRNA vaccines.
During her pharmacy studies she gained first insights in the pharmaceutical industry as an intern within the inhalation characterisation team in the Pharmaceutical Sciences Department of AstraZeneca in Gothenburg.
In 2018 she completed her studies of pharmacy at Kiel University and spent one half of her practical year at Boehringer Ingelheim in Biberach an der Riß. At Boehringer Ingelheim she joined a group handling late-stage drug product development to gain further industrial experience. After being registered as a pharmacist she came back to Kiel University in 2020 to start her PhD in the field of inhalation.
Apart from her research project she is responsible for the practical teaching of pharmaceutics to pharmacy students and continuing her training to become a specialised pharmacist in pharmaceutics and analytics.